The present study explores whether memory impairments are found on the morning following intake of the hypnotic zolpidem which is a member of a new pharmaceutical class, the imidazopyridines. The procedure used is novel: it involves testing subjects in their own homes via the telephone. A previous study using this technique found significant deficits in performance on the morning following intake of the benzodiazepines, flunitrazepam and midazolam, on tasks which load heavily on both the speed and capacity aspects of the human information processing system. Using the same tests, results from the present study fail to find any significant effects on the morning following zolpidem intake.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: